Company: HVIIR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001741
Chunk: 112

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 112
---
 HVII’s initial business combination (excluding any
shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination or any private placement-equivalent
units issued to HVII’s sponsor or its affiliates upon conversion of loans made to HVII). This is different from some other similarly
structured SPACs in which the initial shareholder will only be issued an aggregate of 20% of the total number of shares to be outstanding
prior to the initial business combination. Additionally, the aforementioned adjustment will not take into account any Class A ordinary
shares redeemed in connection with the business combination. Accordingly, the holders of the founder shares could receive additional
Class A ordinary shares even if the additional Class A ordinary shares, or equity-linked securities convertible or exercisable for Class
A ordinary shares, are issued or deemed issued solely to replace those shares that were redeemed in connection with the business combination.
The foregoing may make it more difficult and expensive for HVII to consummate an initial business combination. Further, HVII’s
public shareholders may incur material dilution due to such anti-dilution adjustments that result in the issuance of Class A ordinary
shares on a greater than one-to-one basis upon conversion.

  63  

HVII
may amend the terms of the share rights in a manner that may be adverse to holders of public share rights with the approval by the holders
of at least a majority of then outstanding public share rights. As a result, the exercise price of share rights could be increased, the
exercise period could be shortened and the number of HVII’s Class A ordinary shares purchasable upon exercise of a share right
could be decreased, all without the approval of the holders.

HVII’s
share rights will be issued in registered form under a share right agreement between Odyssey Transfer and Trust Company, as share right
agent, and HVII. The share right agreement provides that the terms of the share rights may be amended without the consent of any holder
for the purpose of (i) curing any ambiguity or correct any mistake, including to conform the provisions of the share right agreement
to the description of the terms of the share rights and the share right agreement attached as an exhibit to HVII’s registration
statement filed in connection with its initial public offering, or defective provision or (ii) adding or changing any provisions with
respect to matters or questions arising under the share right agreement as the parties to the share right agreement may deem necessary
or desirable and that the parties deem to not adversely